Related Experiment Videos
[Clinical experience with clarithromycin in the pediatric field]
The Japanese Journal of Antibiotics
|February 1, 1989
Summary
Clarithromycin (TE-031) demonstrated 75% effectiveness in treating various bacterial infections in 20 children. This antibiotic showed no adverse effects, making it a potentially valuable option for pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Pharmacology
Context:
- Acute bacterial infections are common in children.
- Effective antibiotic treatment is crucial for pediatric patient outcomes.
- Clarithromycin (TE-031) is an antibiotic investigated for pediatric use.
Purpose:
- To evaluate the clinical effectiveness and safety of clarithromycin (TE-031) in children with acute bacterial infections.
- To assess the efficacy of TE-031 across a range of pediatric infections.
Summary:
- Clarithromycin (TE-031) was administered orally to 20 pediatric patients diagnosed with acute bacterial infections, including pharyngitis, tonsillitis, bronchitis, bronchopneumonia, Mycoplasma pneumonia, and impetigo.
- Clinical effectiveness was observed in 15 out of 20 cases (75.0%).
- No clinical side effects or laboratory abnormalities were reported during the study.
Impact:
- The findings suggest clarithromycin (TE-031) is a safe and effective antibiotic for treating various bacterial infections in children.
- This study supports the use of TE-031 as a valuable therapeutic option in pediatric infectious disease management.